Concerning the anti-arthritic action of cetyl myristoleate in rats: An interim report
- 63 Downloads
The proposed arthro-preventive action of cetyl myristoleate, an OTC product sold as a nutritional supplement, could not be confirmed, using an almost identical bioassay (adjuvant-induced polyarthritis in rats) as that described in the original report (Diehl and May, 1994) with the same, and 3 other, dosing schedules.
Key wordsArthritis prevention Cetyl myristoleate Cyclosporin Lyprinol
Unable to display preview. Download preview PDF.
- Diehl, H. W. (1977). Cetyl myristoleate, US patent 4,049,824.Google Scholar
- Diehl, H. W. (1996). Method for the treatment of osteoarthritis, US patent 5,569,676.Google Scholar
- EHP (1997). Myristin dietary supplement. EHP Products (Ashland, Kentucky). Web page (updated Jan 21,1997).Google Scholar
- Haynes, D. R., Gadd, S. J., Whitehouse, M. W., Mayrhofer, G. and Vernon-Roberts, B. (1996). Complete prevention of the clinical expression of adjuvant-induced arthritis in rats by cyclosporin-A and lobenzarit: the regulation of lymph node cell populations and cytokine production, Inflamm. Res. 45, 159–165.PubMedCrossRefGoogle Scholar
- Whitehouse, M. W., Macrides, T. A., Kalafatis, N., Betts, W. H., Haynes, D. R. and Broadbent, J. (1997). Anti-inflammatory activity of a lipid fraction (Lyprinol) from the NZ green-lipped mussel, Inflammopharmacology 5, 237–246.Google Scholar